Author:
Adamcova Michaela,Šimko Fedor
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference18 articles.
1. US President's Council of Advisors on Science and Technology (PCAST) Priorities for Personalized Medicine. Washington DC: Executive Office of the President of United States; 2008.
2. Johnson JA, Cavallari LH. Pharmacogenetics and cardiovascular disease – implication for personalized medicine. Pharmacol Rev 2013; 65: 987–1009.
3. Adamcova M, Lencova-Popelova O, Jirkovsky E, Mazurova Y, Palicka V, Simko F, et al. Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value. Int J Cardiol 2015; 201: 358–67.
4. Adamcova M, Popelova-Lencova O, Jirkovsky E, Simko F, Gersl V, Sterba M. Cardiac troponins: Translational biomarkers in cardiology: Theory and practice of cardiac troponin high-sensitivity assays. Biofactors 2016; 42: 133–48.
5. Taqui S, Daniels LB. Putting it into perspective: multimarker panels for cardiovascular disease risk assessment. Biomark Med 2013; 7: 317–27.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献